Policy Matters

Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

by Brian Rivers, PhD

The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

by Marci A. Landsmann

Forward Look

Studies provide little evidence to support this claim.

by Stephen Ornes

Get Involved

A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.

by Elizabeth Rosto Sitko

Survivor Profile

Mark Good uses every avenue to spread the news about prostate cancer.

by Lindsey Konkel

Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor

The first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.

by Liza Bernstein

The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.

by Emma Yasinski

Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

by Carly Flumer